based in Toronto, told Genentech on April 6 that it had applied for approval from the U.S. Food and Drug Administration to make a generic of Valcyte, according to the complaint filed May 17 in federal court in San Francisco. Genentech, based in South San...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Apple, Google, Microsoft, Kodak, RIM: Intellectual Property
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account